Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

300

To be discontinued: 2 (1%)
Discontinued: 298 (99%)
Reversed: 0 (0%)

Late reports

362 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
ACT NABILONE 0.5MG CAPSULE Resolved 2020-04-16 2021-09-23 112394
ACT NABILONE 0.5MG CAPSULE Resolved 2019-12-19 2020-03-12 101740
ACT NABILONE 1MG CAPSULE Resolved 2019-12-19 2020-03-12 101730
ACT NABILONE 0.5MG CAPSULE Resolved 2020-07-16 2020-08-07 120459
ACT NABILONE 1MG CAPSULE Resolved 2019-10-17 2020-03-12 96733
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
TEVA-OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
TEVA-OLMESARTAN 40MG TABLET Resolved 2018-10-22 2020-06-11 65340
TEVA-OLMESARTAN / HCTZ 12.5MG 20MG TABLET Resolved 2018-10-22 2020-06-11 65343
TEVA-OLMESARTAN / HCTZ 25MG 40MG TABLET Resolved 2018-10-22 2020-06-11 65346
TEVA-OLMESARTAN / HCTZ 12.5MG 40MG TABLET Resolved 2018-09-12 2020-06-11 61359
ACT OLOPATADINE 0.1% 0.1% SOLUTION Actual shortage 2018-10-23 2018-10-23 65519

Showing 181 to 200 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-04-29 2025-04-29 256079
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-TENOFOVIR 300MG TABLET Discontinued 2025-04-29 2025-04-29 256088
TEVA-TOPISONE 0.05% LOTION Discontinued 2024-06-28 2024-06-29 231589
TEVA-TOPOTECAN 4MG POWDER FOR SOLUTION Discontinued 2025-04-29 2025-04-29 256104
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-TRIAMTERENE/HCTZ 25MG 50MG TABLET Discontinued 2017-06-27 2017-06-27 14060
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017

Showing 261 to 280 of 300